Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on April 27, 2026

Apr. 27, 2026

Migración de liquidez de 20,6 billones de dólares: por qué Zoomex está redefiniendo el panorama de los derivados cripto en 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

$20.6 Trillion Liquidity Migration: Why Zoomex is Redefining the Crypto Derivatives Landscape in 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

20 600 milliards de dollars en migration de liquidité : pourquoi Zoomex redéfinit le paysage des dérivés crypto en 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

North American Construction Group Ltd. First Quarter Results Conference Call and Webcast Notification

Indeterminate GlobeNewswire

Apr. 27, 2026

Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Canada's Newcomer Children Have an Academic Integration Gap. A Community-Owned Ontario Startup Just Partnered With Three School Boards to Close It

Indeterminate GlobeNewswire

Apr. 27, 2026

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Seven Goranson Bain Ausley Attorneys Named to D Magazine’s 2026 Best Lawyers in Dallas

Indeterminate GlobeNewswire

Apr. 27, 2026

Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle Cell Disease and Advancements in In Vivo CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

Indeterminate GlobeNewswire

Apr. 27, 2026

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

Indeterminate GlobeNewswire

Apr. 27, 2026

Freddie Mac Issues Monthly Volume Summary for March 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Asgard Therapeutics announces oral presentation at ASGCT 2026, showcasing advanced preclinical data on AT-108 – its first-in-class, off-the-shelf, gene-based cancer immunotherapy

Indeterminate GlobeNewswire

Apr. 27, 2026

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Gulf Resources, Inc. Receives NASDAQ Notice to Late Filing of Its Annual Report

Indeterminate GlobeNewswire

Apr. 27, 2026

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Cellectis présente sa plateforme d’édition épigénétique pour éteindre des gènes sans modifier l’ADN, lors du congrès annuel de l’ASGCT

Indeterminate GlobeNewswire